$RDYN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cardiovascular Systems Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cardiovascular Systems Inc. Get notifications about new insider transactions in Cardiovascular Systems Inc for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 35.55 | 4,037 | 143,531 | 85,067 | 89.1 K to 85.1 K (-4.53 %) |
Feb 20 2014 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Option Exercise | X | 8.83 | 452,729 | 3,997,597 | 0 | |
Feb 20 2014 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Option Exercise | X | 8.83 | 56,558 | 499,407 | 0 | |
Feb 20 2014 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | X | 8.83 | 452,729 | 3,997,597 | 939,257 | 486.5 K to 939.3 K (+93.05 %) |
Feb 20 2014 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | X | 8.83 | 56,558 | 499,407 | 486,528 | 430 K to 486.5 K (+13.15 %) |
Feb 06 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | X | 8.83 | 3,045 | 26,887 | 0 | |
Feb 06 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | X | 8.83 | 3,045 | 26,887 | 87,059 | 84 K to 87.1 K (+3.62 %) |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 50,000 | 441,500 | 50,000 | |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 35.12 | 50,000 | 1,755,760 | 354,052 | 404.1 K to 354.1 K (-12.37 %) |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 50,000 | 441,500 | 404,052 | 354.1 K to 404.1 K (+14.12 %) |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 8.83 | 29,497 | 260,459 | 265 | |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 8.83 | 5,642 | 49,819 | 0 | |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 35.06 | 35,139 | 1,232,100 | 84,014 | 119.2 K to 84 K (-29.49 %) |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 8.83 | 29,497 | 260,459 | 119,153 | 89.7 K to 119.2 K (+32.90 %) |
Feb 03 2014 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 8.83 | 5,642 | 49,819 | 89,656 | 84 K to 89.7 K (+6.72 %) |
Nov 26 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Sell | S | 33.26 | 440 | 14,635 | 59,294 | 59.7 K to 59.3 K (-0.74 %) |
Nov 26 2013 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 33.28 | 1,091 | 36,308 | 202,271 | 203.4 K to 202.3 K (-0.54 %) |
Nov 25 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 95,900 | 846,797 | 100,000 | |
Nov 25 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 33.19 | 33,597 | 1,115,084 | 354,052 | 387.6 K to 354.1 K (-8.67 %) |
Nov 25 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 32.92 | 62,303 | 2,051,015 | 387,649 | 450 K to 387.6 K (-13.85 %) |
Nov 25 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 95,900 | 846,797 | 449,952 | 354.1 K to 450 K (+27.09 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 8.75 | 11,646 | 101,903 | 0 | |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 7.90 | 7,303 | 57,694 | 0 | |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 7.90 | 800 | 6,320 | 7,303 | |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 8.83 | 2,122 | 18,737 | 5,642 | |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 33.21 | 513 | 17,039 | 84,014 | 84.5 K to 84 K (-0.61 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 33.18 | 10,983 | 364,416 | 84,527 | 95.5 K to 84.5 K (-11.50 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 32.56 | 10,088 | 328,465 | 95,510 | 105.6 K to 95.5 K (-9.55 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 8.75 | 11,646 | 101,903 | 105,598 | 94 K to 105.6 K (+12.40 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 7.90 | 7,303 | 57,694 | 93,952 | 86.6 K to 94 K (+8.43 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 8.83 | 2,122 | 18,737 | 86,649 | 84.5 K to 86.6 K (+2.51 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 30.90 | 800 | 24,720 | 84,527 | 85.3 K to 84.5 K (-0.94 %) |
Nov 22 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 7.90 | 800 | 6,320 | 85,327 | 84.5 K to 85.3 K (+0.95 %) |
Nov 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.90 | 4,296 | 128,458 | 89,104 | 93.4 K to 89.1 K (-4.60 %) |
Nov 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.83 | 5,018 | 149,673 | 93,400 | 98.4 K to 93.4 K (-5.10 %) |
Nov 15 2013 | RDYN | Cardiovascular Sys ... | WARD SCOTT R | Director | Option Exercise | A | 0.00 | 2,874 | 0 | 2,874 | |
Nov 13 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Option Exercise | X | 8.83 | 940 | 8,300 | 0 | |
Nov 13 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Sell | S | 29.67 | 280 | 8,308 | 59,734 | 60 K to 59.7 K (-0.47 %) |
Nov 13 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Buy | X | 8.83 | 940 | 8,300 | 60,014 | 59.1 K to 60 K (+1.59 %) |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Option Exercise | X | 8.83 | 22,356 | 197,403 | 0 | |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Buy | X | 8.83 | 22,356 | 197,403 | 54,645 | 32.3 K to 54.6 K (+69.24 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 7.90 | 7,326 | 57,875 | 8,103 | |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 7.90 | 5,942 | 46,942 | 15,429 | |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 30.92 | 7,326 | 226,516 | 84,527 | 91.9 K to 84.5 K (-7.98 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 7.90 | 7,326 | 57,875 | 91,853 | 84.5 K to 91.9 K (+8.67 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 30.94 | 5,942 | 183,855 | 84,527 | 90.5 K to 84.5 K (-6.57 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 7.90 | 5,942 | 46,942 | 90,469 | 84.5 K to 90.5 K (+7.03 %) |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Option Exercise | X | 8.83 | 151,617 | 1,338,778 | 0 | |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Option Exercise | X | 8.83 | 151,617 | 1,338,778 | 0 | |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 29.71 | 45,065 | 1,338,881 | 166,112 | 211.2 K to 166.1 K (-21.34 %) |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Buy | X | 8.83 | 151,617 | 1,338,778 | 211,177 | 59.6 K to 211.2 K (+254.56 %) |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 29.71 | 45,065 | 1,338,881 | 527,575 | 572.6 K to 527.6 K (-7.87 %) |
Nov 12 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Buy | X | 8.83 | 151,617 | 1,338,778 | 572,640 | 421 K to 572.6 K (+36.01 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 4,100 | 36,203 | 195,900 | |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 31.02 | 4,100 | 127,202 | 354,052 | 358.2 K to 354.1 K (-1.14 %) |
Nov 05 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 4,100 | 36,203 | 358,152 | 354.1 K to 358.2 K (+1.16 %) |
Oct 30 2013 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Option Exercise | X | 8.83 | 44,713 | 394,816 | 0 | |
Oct 30 2013 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Buy | X | 8.83 | 44,713 | 394,816 | 44,713 | 0 to 44.7 K |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 8.75 | 10,999 | 96,241 | 0 | |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 12.15 | 23,620 | 286,983 | 0 | |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 12.15 | 200 | 2,430 | 23,620 | |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 30.35 | 34,619 | 1,050,804 | 132,366 | 167 K to 132.4 K (-20.73 %) |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 8.75 | 10,999 | 96,241 | 166,985 | 156 K to 167 K (+7.05 %) |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 12.15 | 23,620 | 286,983 | 155,986 | 132.4 K to 156 K (+17.84 %) |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 30.00 | 200 | 6,000 | 132,366 | 132.6 K to 132.4 K (-0.15 %) |
Nov 01 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 12.15 | 200 | 2,430 | 132,566 | 132.4 K to 132.6 K (+0.15 %) |
Oct 30 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Option Exercise | X | 8.83 | 2,739 | 24,185 | 0 | |
Oct 30 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Buy | X | 8.83 | 2,739 | 24,185 | 32,289 | 29.6 K to 32.3 K (+9.27 %) |
Oct 25 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Option Exercise | M | 7.90 | 1,274 | 10,065 | 21,371 | |
Oct 25 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 28.21 | 22,152 | 624,810 | 84,527 | 106.7 K to 84.5 K (-20.77 %) |
Oct 25 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 27.90 | 1,274 | 35,545 | 106,679 | 108 K to 106.7 K (-1.18 %) |
Oct 25 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Buy | M | 7.90 | 1,274 | 10,065 | 107,953 | 106.7 K to 108 K (+1.19 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 50,000 | 441,500 | 200,000 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 29,363 | 259,275 | 250,000 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 24,717 | 218,251 | 279,363 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 50,000 | 441,500 | 0 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 29.39 | 50,000 | 1,469,735 | 354,052 | 404.1 K to 354.1 K (-12.37 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 50,000 | 441,500 | 404,052 | 354.1 K to 404.1 K (+14.12 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 28.15 | 9,086 | 255,771 | 354,052 | 363.1 K to 354.1 K (-2.50 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 27.29 | 20,277 | 553,359 | 363,138 | 383.4 K to 363.1 K (-5.29 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 29,363 | 259,275 | 383,415 | 354.1 K to 383.4 K (+8.29 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 27.09 | 37,142 | 1,006,177 | 354,052 | 391.2 K to 354.1 K (-9.49 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 26.27 | 37,575 | 987,133 | 391,194 | 428.8 K to 391.2 K (-8.76 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 24,717 | 218,251 | 428,769 | 404.1 K to 428.8 K (+6.12 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 50,000 | 441,500 | 404,052 | 354.1 K to 404.1 K (+14.12 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 27.31 | 5,608 | 153,154 | 98,418 | 104 K to 98.4 K (-5.39 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 12.15 | 300 | 3,645 | 23,820 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 7.90 | 19,388 | 153,165 | 0 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Option Exercise | M | 8.83 | 8,624 | 76,150 | 0 | |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 30.00 | 300 | 9,000 | 132,366 | 132.7 K to 132.4 K (-0.23 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 12.15 | 300 | 3,645 | 132,666 | 132.4 K to 132.7 K (+0.23 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 27.25 | 17,626 | 480,309 | 132,366 | 150 K to 132.4 K (-11.75 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 26.42 | 18,756 | 495,534 | 149,992 | 168.7 K to 150 K (-11.11 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 7.90 | 19,388 | 153,165 | 168,748 | 149.4 K to 168.7 K (+12.98 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Buy | M | 8.83 | 8,624 | 76,150 | 149,360 | 140.7 K to 149.4 K (+6.13 %) |
Oct 18 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 22.90 | 23,426 | 536,455 | 106,679 | 130.1 K to 106.7 K (-18.01 %) |
Oct 18 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 22.95 | 4,182 | 95,977 | 104,026 | 108.2 K to 104 K (-3.86 %) |
Oct 16 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Option Exercise | M | 8.83 | 21,170 | 186,931 | 50,000 | |
Oct 16 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 22.00 | 21,170 | 465,740 | 354,052 | 375.2 K to 354.1 K (-5.64 %) |
Oct 16 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Buy | M | 8.83 | 21,170 | 186,931 | 375,222 | 354.1 K to 375.2 K (+5.98 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 20.06 | 193 | 3,872 | 130,105 | 130.3 K to 130.1 K (-0.15 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 20.32 | 1,081 | 21,966 | 130,298 | 131.4 K to 130.3 K (-0.82 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 20.03 | 1,850 | 37,056 | 354,052 | 355.9 K to 354.1 K (-0.52 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 20.32 | 4,852 | 98,593 | 355,902 | 360.8 K to 355.9 K (-1.34 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Sell | S | 20.32 | 1,094 | 22,230 | 59,074 | 60.2 K to 59.1 K (-1.82 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 19.90 | 142 | 2,826 | 108,208 | 108.4 K to 108.2 K (-0.13 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.32 | 1,179 | 23,957 | 108,350 | 109.5 K to 108.4 K (-1.08 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 19.82 | 184 | 3,647 | 140,736 | 140.9 K to 140.7 K (-0.13 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 20.32 | 1,882 | 38,242 | 140,920 | 142.8 K to 140.9 K (-1.32 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 20.32 | 2,694 | 54,742 | 203,362 | 206.1 K to 203.4 K (-1.31 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 20.91 | 1,076 | 22,499 | 131,379 | 132.5 K to 131.4 K (-0.81 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 20.98 | 655 | 13,742 | 132,455 | 133.1 K to 132.5 K (-0.49 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 20.91 | 4,823 | 100,849 | 360,754 | 365.6 K to 360.8 K (-1.32 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 20.98 | 3,207 | 67,283 | 365,577 | 368.8 K to 365.6 K (-0.87 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Sell | S | 20.91 | 1,114 | 23,294 | 60,168 | 61.3 K to 60.2 K (-1.82 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Sell | S | 20.98 | 618 | 12,966 | 61,282 | 61.9 K to 61.3 K (-1.00 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 20.91 | 2,790 | 58,339 | 206,056 | 208.8 K to 206.1 K (-1.34 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 20.98 | 1,534 | 32,183 | 208,846 | 210.4 K to 208.8 K (-0.73 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.91 | 1,171 | 24,486 | 109,529 | 110.7 K to 109.5 K (-1.06 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.98 | 695 | 14,581 | 110,700 | 111.4 K to 110.7 K (-0.62 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 20.91 | 1,871 | 39,123 | 142,802 | 144.7 K to 142.8 K (-1.29 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 20.98 | 1,099 | 23,057 | 144,673 | 145.8 K to 144.7 K (-0.75 %) |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Option Exercise | X | 9.28 | 117,399 | 1,089,463 | 0 | |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Option Exercise | X | 9.28 | 53,916 | 500,340 | 0 | |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Sell | X | 9.28 | 117,399 | 1,089,463 | 429,970 | 547.4 K to 430 K (-21.45 %) |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Sell | X | 9.28 | 53,916 | 500,340 | 312,571 | 366.5 K to 312.6 K (-14.71 %) |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Option Exercise | X | 9.28 | 5,797 | 53,796 | 0 | |
Sep 16 2013 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Sell | X | 9.28 | 5,797 | 53,796 | 29,550 | 35.3 K to 29.6 K (-16.40 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 1,552 | 0 | 133,110 | 131.6 K to 133.1 K (+1.18 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Grant | A | 0.00 | 1,478 | 0 | 61,900 | 60.4 K to 61.9 K (+2.45 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 1,478 | 0 | 111,395 | 109.9 K to 111.4 K (+1.34 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 6,823 | 0 | 368,784 | 362 K to 368.8 K (+1.89 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Grant | A | 0.00 | 3,286 | 0 | 210,380 | 207.1 K to 210.4 K (+1.59 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Grant | A | 0.00 | 2,347 | 0 | 145,772 | 143.4 K to 145.8 K (+1.64 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Option Exercise | X | 9.28 | 107,833 | 1,000,690 | 0 | |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 20.73 | 48,273 | 1,000,699 | 59,560 | 107.8 K to 59.6 K (-44.77 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Buy | X | 9.28 | 107,833 | 1,000,690 | 107,833 | 0 to 107.8 K |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 2,187 | 0 | 131,558 | 129.4 K to 131.6 K (+1.69 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 2,187 | 0 | 129,371 | 127.2 K to 129.4 K (+1.72 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 7,291 | 0 | 127,184 | 119.9 K to 127.2 K (+6.08 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 3,645 | 0 | 119,893 | 116.2 K to 119.9 K (+3.14 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 3,645 | 0 | 116,248 | 112.6 K to 116.2 K (+3.24 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 7,420 | 0 | 361,961 | 354.5 K to 362 K (+2.09 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 7,420 | 0 | 354,541 | 347.1 K to 354.5 K (+2.14 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 24,736 | 0 | 347,121 | 322.4 K to 347.1 K (+7.67 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 12,368 | 0 | 322,385 | 310 K to 322.4 K (+3.99 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 12,368 | 0 | 310,017 | 297.6 K to 310 K (+4.16 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Grant | A | 0.00 | 2,083 | 0 | 60,422 | 58.3 K to 60.4 K (+3.57 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Grant | A | 0.00 | 2,083 | 0 | 58,339 | 56.3 K to 58.3 K (+3.70 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Koehn Paul A | SVP Quality & Opera ... | Grant | A | 0.00 | 6,944 | 0 | 56,256 | 49.3 K to 56.3 K (+14.08 %) |